These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32142087)

  • 61. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides.
    Han SE; Kang H; Shim GY; Kim SJ; Choi HG; Kim J; Hahn SK; Oh YK
    J Drug Target; 2009 Feb; 17(2):123-32. PubMed ID: 19012052
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Contrast viscosity changes upon photoirradiation for mixtures of poly(acrylic acid)-based alpha-cyclodextrin and azobenzene polymers.
    Tomatsu I; Hashidzume A; Harada A
    J Am Chem Soc; 2006 Feb; 128(7):2226-7. PubMed ID: 16478172
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery.
    Jang YL; Ku SH; Jin S; Park JH; Kim WJ; Kwon IC; Kim SH; Jeong JH
    J Nanosci Nanotechnol; 2014 Oct; 14(10):7388-94. PubMed ID: 25942799
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Supramolecular host-guest polycationic gene delivery system based on poly(cyclodextrin) and azobenzene-terminated polycations.
    Jiang Q; Zhang Y; Zhuo R; Jiang X
    Colloids Surf B Biointerfaces; 2016 Nov; 147():25-35. PubMed ID: 27478960
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery.
    Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q
    J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis and characterization of polyrotaxanes consisting of cationic alpha-cyclodextrins threaded on poly[(ethylene oxide)-ran-(propylene oxide)] as gene carriers.
    Yang C; Wang X; Li H; Goh SH; Li J
    Biomacromolecules; 2007 Nov; 8(11):3365-74. PubMed ID: 17929967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
    Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X
    J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor Targeting and Lipid Rafts Disrupting Hyaluronic Acid-Cyclodextrin-Based Nanoassembled Structure for Cancer Therapy.
    Lee SY; Ko SH; Shim JS; Kim DD; Cho HJ
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36628-36640. PubMed ID: 30298719
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems.
    Fernandez-Piñeiro I; Pensado A; Badiola I; Sanchez A
    Eur J Pharm Biopharm; 2018 Apr; 125():85-94. PubMed ID: 29355685
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor-Targeting Anti-MicroRNA-155 Delivery Based on Biodegradable Poly(ester amine) and Hyaluronic Acid Shielding for Lung Cancer Therapy.
    Yang Y; Jia Y; Xiao Y; Hao Y; Zhang L; Chen X; He J; Zhao Y; Qian Z
    Chemphyschem; 2018 Aug; 19(16):2058-2069. PubMed ID: 29488305
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro and in vivo siRNA delivery to hepatocyte utilizing ternary complexation of lactosylated dendrimer/cyclodextrin conjugates, siRNA and low-molecular-weight sacran.
    Hayashi Y; Higashi T; Motoyama K; Jono H; Ando Y; Arima H
    Int J Biol Macromol; 2018 Feb; 107(Pt A):1113-1121. PubMed ID: 28964842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
    Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
    Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tunable Supramolecular Assembly and Photoswitchable Conversion of Cyclodextrin/Diphenylalanine-Based 1D and 2D Nanostructures.
    Sun HL; Chen Y; Han X; Liu Y
    Angew Chem Int Ed Engl; 2017 Jun; 56(25):7062-7065. PubMed ID: 28517106
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).
    Arima H; Chihara Y; Arizono M; Yamashita S; Wada K; Hirayama F; Uekama K
    J Control Release; 2006 Nov; 116(1):64-74. PubMed ID: 17083992
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells.
    Bools LM; Fisher RK; Grandas OH; Kirkpatrick SS; Arnold JD; Goldman MH; Freeman MB; Mountain DJ
    J Surg Res; 2015 Nov; 199(1):266-73. PubMed ID: 26272685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gold-installed biostable nanocomplexes for tumor-targeted siRNA delivery in vivo.
    Heo R; Yoon HY; Ko H; Shin JM; Jeon J; Chae YS; Kang YM; Kim D; Lee DS; Park JH
    Chem Commun (Camb); 2015 Dec; 51(93):16656-9. PubMed ID: 26426483
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hydrophobic polyalanine modified hyperbranched polyethylenimine as high efficient pDNA and siRNA carrier.
    Guo Z; Tian H; Lin L; Chen J; He C; Tang Z; Chen X
    Macromol Biosci; 2014 Oct; 14(10):1406-14. PubMed ID: 24948023
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model.
    Ball RL; Knapp CM; Whitehead KA
    PLoS One; 2015; 10(7):e0133154. PubMed ID: 26192592
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.